72.11.Z - Research and experimental development on biotechnology
20.13.Z - Manufacture of other inorganic basic chemicals
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
22.2 - Manufacture of plastic products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 1,8 | 2 | 2 | -0 |
Gross profit (loss) | 0,1 | -0 | 0 | 280,4 |
Net profit (loss) | 0,1 | -0 | 0 | 280,4 |
Liabilities and provisions for liabilities | 0,6 | 0,7 | 0,7 | -4,3 |
Income tax | 0 | 0 | 0 | 0 |
Working assets | 1,5 | 1,6 | 1,6 | -0,1 |
Equity capital | 1,2 | 1,2 | 1,2 | 2,6 |
Basic operational activity income | 0,2 | -0 | 0 | 100 |
% | % | % | p.p. | |
Profitability of capital | 9,1 | -1,4 | 2,5 | 3,9 |
Equity capital to total assets | 68,4 | 61,6 | 63,3 | 1,7 |
Gross profit margin | 53,5 | 3266,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane